315 related articles for article (PubMed ID: 10566625)
1. The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life.
Barnhart KT; Freeman E; Grisso JA; Rader DJ; Sammel M; Kapoor S; Nestler JE
J Clin Endocrinol Metab; 1999 Nov; 84(11):3896-902. PubMed ID: 10566625
[TBL] [Abstract][Full Text] [Related]
2. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales AJ; Nolan JJ; Nelson JC; Yen SS
J Clin Endocrinol Metab; 1994 Jun; 78(6):1360-7. PubMed ID: 7515387
[TBL] [Abstract][Full Text] [Related]
3. Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men.
Srinivasan M; Irving BA; Frye RL; O'Brien P; Hartman SJ; McConnell JP; Nair KS
J Clin Endocrinol Metab; 2010 Apr; 95(4):1617-25. PubMed ID: 20139233
[TBL] [Abstract][Full Text] [Related]
4. Effects of transdermal application of DHEA on the levels of steroids, gonadotropins and lipids in men.
Sulcová J; Hill M; Hampl R; Masek Z; Novácek A; Ceska R; Stárka L
Physiol Res; 2000; 49(6):685-93. PubMed ID: 11252535
[TBL] [Abstract][Full Text] [Related]
5. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
6. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
Libè R; Barbetta L; Dall'Asta C; Salvaggio F; Gala C; Beck-Peccoz P; Ambrosi B
J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
[TBL] [Abstract][Full Text] [Related]
7. Effects of transdermal application of 7-oxo-DHEA on the levels of steroid hormones, gonadotropins and lipids in healthy men.
Sulcová J; Hill M; Masek Z; Ceska R; Novácek A; Hampl R; Stárka L
Physiol Res; 2001; 50(1):9-18. PubMed ID: 11300231
[TBL] [Abstract][Full Text] [Related]
8. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
Johannsson G; Burman P; Wirén L; Engström BE; Nilsson AG; Ottosson M; Jonsson B; Bengtsson BA; Karlsson FA
J Clin Endocrinol Metab; 2002 May; 87(5):2046-52. PubMed ID: 11994339
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and hormonal effects of oral DHEA in premenopausal women with HIV infection: a randomized, prospective, placebo-controlled pilot study.
Poretsky L; Song L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison C; Haller I; Rabkin J
Horm Metab Res; 2009 Mar; 41(3):244-9. PubMed ID: 18810712
[TBL] [Abstract][Full Text] [Related]
10. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
11. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
Wolf OT; Neumann O; Hellhammer DH; Geiben AC; Strasburger CJ; Dressendörfer RA; Pirke KM; Kirschbaum C
J Clin Endocrinol Metab; 1997 Jul; 82(7):2363-7. PubMed ID: 9215320
[TBL] [Abstract][Full Text] [Related]
12. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods.
von Mühlen D; Laughlin GA; Kritz-Silverstein D; Barrett-Connor E
Contemp Clin Trials; 2007 Feb; 28(2):153-68. PubMed ID: 16784898
[TBL] [Abstract][Full Text] [Related]
13. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK
J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
[TBL] [Abstract][Full Text] [Related]
14. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial.
Hartkamp A; Geenen R; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
Ann Rheum Dis; 2008 Jan; 67(1):91-7. PubMed ID: 17545193
[TBL] [Abstract][Full Text] [Related]
15. [The level of cortisol, DHEA, DHEA-s in plasma serum and the connection with the lipids and response to treatment in women with depression].
Janota B; Załuska M
Psychiatr Pol; 2011; 45(6):861-73. PubMed ID: 22335129
[TBL] [Abstract][Full Text] [Related]
16. Dhea supplementation and cognition in postmenopausal women.
Parsons TD; Kratz KM; Thompson E; Stanczyk FZ; Buckwalter JG
Int J Neurosci; 2006 Feb; 116(2):141-55. PubMed ID: 16393880
[TBL] [Abstract][Full Text] [Related]
17. DHEA in elderly women and DHEA or testosterone in elderly men.
Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
[TBL] [Abstract][Full Text] [Related]
18. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
Martina V; Benso A; Gigliardi VR; Masha A; Origlia C; Granata R; Ghigo E
Clin Endocrinol (Oxf); 2006 Mar; 64(3):260-4. PubMed ID: 16487434
[TBL] [Abstract][Full Text] [Related]
19. Dehydroepiandrosterone (DHEA) supplementation for cognitive function .
Huppert FA; Van Niekerk JK
Cochrane Database Syst Rev; 2001; (2):CD000304. PubMed ID: 11405958
[TBL] [Abstract][Full Text] [Related]
20. Long-term low-dose dehydroepiandrosterone replacement therapy in aging males with partial androgen deficiency.
Genazzani AR; Inglese S; Lombardi I; Pieri M; Bernardi F; Genazzani AD; Rovati L; Luisi M
Aging Male; 2004 Jun; 7(2):133-43. PubMed ID: 15672938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
